Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.

BACKGROUND: Interferon-α/ribavirin combination therapy might promote hepatitis B surface antigen (HBsAg) seroclearance in patients dually infected with hepatitis B and C viruses (HBV/HCV), but the long-term effect remains unclear. We aimed to investigate the rate of and the factors associated with H...

Full description

Bibliographic Details
Main Authors: Ming-Lun Yeh, Chao-Hung Hung, Jee-Fu Huang, Chun-Jen Liu, Chuan-Mo Lee, Chia-Yen Dai, Jing-Houng Wang, Zu-Yau Lin, Sheng-Nan Lu, Tsung-Hui Hu, Ming-Lung Yu, Jia-Horng Kao, Wan-Long Chuang, Pei-Jer Chen, Ding-Shinn Chen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3113900?pdf=render